ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing (PR Newswire)
Yahoo Finance • Aug 7, 2008ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M in an extended Series B venture round to expand its development pipeline. Full Story »
-
Topics:
- B Round
- Venture Capital Financing
- Pipeline
